Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $20.04 USD
Change Today +0.24 / 1.21%
Volume 15.9K
EXAC On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 12:29 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

exactech inc (EXAC) Key Developments

Exactech Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Third Quarter Ending September 30, 2015 and Fiscal Year 2015

Exactech Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of $61,493,000 against $63,919,000 a year ago. Income from operations was $6,135,000 against $6,814,000 a year ago. Income before income taxes was $5,342,000 against $6,472,000 a year ago. Net income was $3,661,000 or $0.26 per diluted share against $4,160,000 or $0.30 per diluted share a year ago. For the six months, the company reported net sales of $122,869,000 against $127,177,000 a year ago. Income from operations was $12,201,000 against $13,425,000 a year ago. Income before income taxes was $10,934,000 against $13,076,000 a year ago. Net income was $7,773,000 or $0.55 per diluted share against $8,358,000 or $0.60 per diluted share a year ago. For the third quarter ending September 30, 2015, the company said it anticipates revenues of $58.0 million -$60.0 million and diluted EPS of $0.23-$0.25. For the year 2015, the company updated its 2015 revenue guidance to $246 million -$250 million and its diluted EPS target to $1.16 to $1.20.

Exactech Inc. to Report Q2, 2015 Results on Jul 28, 2015

Exactech Inc. announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Jul 28, 2015

Exactech Inc., Q2 2015 Earnings Call, Jul 29, 2015

Exactech Inc., Q2 2015 Earnings Call, Jul 29, 2015

Exactech, Inc. Receives FDA 510(K) Clearance for Optetrak Logic® Constrained Condylar Prosthesis

Exactech Inc. announced that it has received clearance from the U.S. Food and Drug Administration to market the Optetrak Logic® Constrained Condylar (CC) Prosthesis for revision knee arthroplasty cases. A surgeon-focused, patient-driven innovation, Optetrak Logic CC offers a modern solution for reproducibility in the most complex and challenging knee arthroplasty cases. The new addition to Exactech’s clinically recognized knee system introduces an advanced implant system and precision tools to consistently achieve optimized implant placement and bone coverage. The Optetrak Logic CC Prosthesis is indicated for use in patients undergoing surgery for total knee replacement due to osteoarthritis, osteonecrosis, rheumatoid arthritis and/or post-traumatic degenerative problems; this device is also indicated for when previous devices have failed.

Exactech Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Revenue Guidance for the Second Quarter Ending June 30, 2015; Provides Revenue Guidance for the Year 2015

Exactech Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of $61,376,000 against $63,258,000 a year ago. Income from operations was $6,066,000 against $6,611,000 a year ago. Income before income taxes was $5,592,000 against $6,604,000 a year ago. Net income was $4,112,000 against $4,198,000 a year ago. Diluted earnings per share were $0.29 against $0.30 per share a year ago. For the year 2015, the company’s revenue guidance to $248 million to $254 million and its diluted EPS target to $1.18 to $1.24. The company expects the tax rate to be 33% to 34% for the balance of the year. For the second quarter ending June 30, 2015, the company anticipates revenues of $61 to $63 and diluted EPS of $0.26 to $0.28. The company continues to expect gross margins to decrease approximately 50 basis points on a comparative quarter basis due to the continued impact of pricing, as well as the impact of foreign exchange rates where they currently reside. The company expects to experience a compression of operating margin in the second quarter, primarily due to the impact of the FX rate.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAC:US $20.04 USD +0.24

EXAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.39 USD +0.03
Mercury Systems Inc $14.15 USD +0.18
RTI Surgical Inc $7.23 USD +0.415
SigmaTron International Inc $6.40 USD -0.01
SMTC Corp $1.69 USD 0.00
View Industry Companies
 

Industry Analysis

EXAC

Industry Average

Valuation EXAC Industry Range
Price/Earnings 17.8x
Price/Sales 1.1x
Price/Book 1.3x
Price/Cash Flow 8.5x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACTECH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.